Second, long-term studies in GHD children do not show any increase in the incidence of tumors; moreover, the slight increase in the incidence of a second tumor detected in children with GHD secondary to leukemia treated with associated prophylactic brain radiotherapy, has been shown to be a consequence of the radiotherapy and not of the treatment with GH. This evidence concerns the gene GH1 and leukemia.